BioSig raises $1.37M via PIPE of common stock and warrants

Streamex Corp.

Entered Securities Purchase Agreement on Feb 3, 2023 for sale of 1,591,750 shares at $0.8588/share and warrants for 795,875 shares at $0.7963, total proceeds $1.37M.
Warrants exercisable six months after issuance, expire 5.5 years from issuance.
Laidlaw & Company received placement agent warrants for 87,331 shares (Feb PIPE) and 71,214 shares (Jan PIPE).
Securities issued in reliance on Section 4(a)(2) and Regulation D exemption.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Streamex Corp. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at $1,366,994.90 (effective 2023-02-03).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional and accredited investors
Value: $1,366,994.90
Effective: 2023-02-03

Exact text from the filing

On February 3, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company sold to the Investors an aggregate of 1,591,750 shares (the “Shares”) of the Company’s common stock

View on SEC.gov

277 material agreements filed in the last 30 days. Browse all material agreements →

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001185185-23-000102

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.